.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
AIIMS Delhi Director Dr M Srinivas recently urged stakeholders to support the nationwide HPV vaccination drive. Consequently, he called upon parents, teachers, and community leaders to promote this critical health initiative. Prime Minister Narendra Modi launched this campaign to improve public health across the country. Furthermore, the initiative has the potential to save countless lives by preventing cervical cancer. This landmark move represents a transformative moment in India's medical history.
Cervical cancer remains a leading cause of cancer deaths among women in India. However, medical experts emphasize that this disease is largely preventable through timely intervention. Scientists have validated the Human Papillomavirus (HPV) vaccine as a safe and highly effective tool. Additionally, systematic administration to girls aged 9 to 14 years provides powerful protection. Therefore, the government aims to reach girls early to ensure maximum benefit and protection.
Vaccination remains one of the most cost-effective public health interventions today. Specifically, the drive helps ease the financial burden on families. Moreover, preventive healthcare serves as the cornerstone of a resilient health system. Dr Srinivas highlighted that every eligible girl should benefit from this life-saving intervention. Collectively, these efforts envision a future where cervical cancer is no longer a public health threat.
Q1: Who is eligible for the HPV vaccine under this drive?
The current nationwide drive primarily targets adolescent girls between the ages of 9 and 14 years to ensure maximum efficacy before any potential viral exposure.
Q2: Is the HPV vaccine safe and scientifically proven?
Yes, medical professionals confirm that the HPV vaccine is safe, scientifically validated, and has been used successfully in global immunization programs for years.
Q3: Why is it important to vaccinate at a young age?
Vaccinating girls at the recommended age provides robust protection before potential exposure to the virus, significantly reducing the risk of developing cervical cancer in adulthood.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
AIIMS Delhi Director Dr M Srinivas urges support for India's nationwide HPV vaccination drive launched by PM Modi to combat cervical cancer effectively....
5 months ago
A Bayesian network meta-analysis evaluated non-surgical treatments for benign thyroid nodules, finding thermal ablation techniques like laser and radiofrequency ablation superior in nodule volume reduction, whereas levothyroxine showed the strongest TSH suppression without significant changes in FT3 or FT4.
Today
A retrospective study demonstrates that deep learning models using longitudinal digital breast tomosynthesis significantly enhance 5-year breast cancer risk prediction compared to single-timepoint imaging and clinical models.
Today
Researchers developed poly(trimethylene carbonate)-based polymersomes loaded with L-arginine for ROS-triggered nitric oxide release. This mild, stable nano-delivery system produces gas in response to hydrogen peroxide, offering a promising, targeted platform for cardiovascular, surgical, and oncological therapy.
Today
Researchers developed a Haversian-inspired composite scaffold that addresses delayed vascularization and wet-state mechanical deterioration in critical bone defect repair. By integrating spatially programmed calcium phosphate minerals and selective silica reinforcement, the design promotes vascularized bone repair.
Yesterday
A landmark study analyzing over 56,000 adult health records in Delhi-NCR reveals that hypertension and diabetes coexistence affects nearly 5% of adults. The prevalence doubles expected rates and rises sharply after age 40. Early integrated screening is essential to prevent microvascular and macrovascular complications.
Today
